160 related articles for article (PubMed ID: 35398345)
1. Effectiveness and Safety of Fecal Microbiota Transplantation for Clostridioides Difficile Infection: Results From a 5344-Patient Cohort Study.
Osman M; Budree S; Kelly CR; Panchal P; Allegretti JR; Kassam Z;
Gastroenterology; 2022 Jul; 163(1):319-322. PubMed ID: 35398345
[No Abstract] [Full Text] [Related]
2. Advances in
Khanna S
Expert Rev Anti Infect Ther; 2021 Sep; 19(9):1067-1070. PubMed ID: 33427531
[No Abstract] [Full Text] [Related]
3. Faecal microbiota transplantation for
Terveer EM; Vendrik KE; Ooijevaar RE; Lingen EV; Boeije-Koppenol E; Nood EV; Goorhuis A; Bauer MP; van Beurden YH; Dijkgraaf MG; Mulder CJ; Vandenbroucke-Grauls CM; Seegers JF; van Prehn J; Verspaget HW; Kuijper EJ; Keller JJ
United European Gastroenterol J; 2020 Dec; 8(10):1236-1247. PubMed ID: 32990503
[TBL] [Abstract][Full Text] [Related]
4. Faecal banking at -20 °C facilitates faecal microbiota transplantation for recurrent
Satokari R; Pietilä L; Mattila E; Lahtinen P; Arkkila PET
Infect Dis (Lond); 2020 Sep; 52(9):662-665. PubMed ID: 32516025
[No Abstract] [Full Text] [Related]
5. Pediatric Fecal Microbiota Transplantation in Recurrent
Parnell JM; Nicholson MR; Kellermayer R; Kahn SA
Pediatr Ann; 2021 Dec; 50(12):e515-e521. PubMed ID: 34889135
[TBL] [Abstract][Full Text] [Related]
6. Fecal Microbiota Transplantation for Clostridioides difficile in High-Risk Older Adults Is Associated with Early Recurrence.
Luo Y; Tixier EN; Grinspan AM
Dig Dis Sci; 2020 Dec; 65(12):3647-3651. PubMed ID: 32078714
[TBL] [Abstract][Full Text] [Related]
7. Fecal microbiota transplantation for treatment of patients with recurrent
Voth E; Khanna S
Expert Rev Anti Infect Ther; 2020 Jul; 18(7):669-676. PubMed ID: 32266848
[TBL] [Abstract][Full Text] [Related]
8. Sex-Discordant Fecal Microbiota Transplantation for Clostridioides difficile May Increase Risk of Postinfection Irritable Bowel Syndrome.
Sehgal K; Yadav D; Saha S; Mara K; Grover M; Khanna S
Gastroenterology; 2024 Apr; 166(4):704-706.e2. PubMed ID: 38056511
[No Abstract] [Full Text] [Related]
9. Systematic Review with Meta-Analysis: Fecal Microbiota Transplantation for Severe or Fulminant Clostridioides difficile.
Tixier EN; Verheyen E; Luo Y; Grinspan LT; Du CH; Ungaro RC; Walsh S; Grinspan AM
Dig Dis Sci; 2022 Mar; 67(3):978-988. PubMed ID: 33748913
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of fecal microbiota transplant for the treatment of Clostridioides difficile diarrhea: a systematic review and meta-analysis.
Pomares Bascuñana RÁ; Veses V; Sheth CC
Lett Appl Microbiol; 2021 Aug; 73(2):149-158. PubMed ID: 33864273
[TBL] [Abstract][Full Text] [Related]
11. Fecal microbiota transplantation: a review on current formulations in
Rakotonirina A; Galperine T; Allémann E
Expert Opin Biol Ther; 2022 Jul; 22(7):929-944. PubMed ID: 35763604
[TBL] [Abstract][Full Text] [Related]
12. Fecal Microbiota Transplantation Across the Lifespan: Balancing Efficacy, Safety, and Innovation.
Gulati AS; Nicholson MR; Khoruts A; Kahn SA
Am J Gastroenterol; 2023 Mar; 118(3):435-439. PubMed ID: 36580630
[TBL] [Abstract][Full Text] [Related]
13. Commercialized fecal microbiota transplantation provides efficacious treatment of Clostridium difficile infection.
Martinez C; Edwards J; Hassoun A
Infect Dis (Lond); 2018; 50(11-12):864-867. PubMed ID: 30265170
[No Abstract] [Full Text] [Related]
14. Diarrhea after fecal microbiota transplantation for recurrent
Krensky C; Poutanen SM; Hota SS
CMAJ; 2019 May; 191(20):E559-E561. PubMed ID: 31113785
[No Abstract] [Full Text] [Related]
15. Romanian National Guideline on Translating Fecal Microbiota Transplantation Applications related to Clostridioides difficile Infections into the Local Clinical Practice.
Gilca-Blanariu GE; Stefanescu G; Girleanu I; Iqbal T; Segal J; Mullish B; Quraishi MN; Keller J; Molnar T; Megraud F; Dumitrascu D; Manuc M; Iancu LS; Marica C; Gheorghe C; Manzoor S; Trifan A
J Gastrointestin Liver Dis; 2021 Mar; 30(1):147-163. PubMed ID: 33723543
[TBL] [Abstract][Full Text] [Related]
16. Fecal microbiota transplantation as an early therapeutic option in treatment refractory Clostridioides difficile infection.
Buldukoglu OC; Ocal S; Cekin AH
J Gastroenterol Hepatol; 2024 Jun; 39(6):1200. PubMed ID: 38454297
[No Abstract] [Full Text] [Related]
17. Fecal microbiota transplantation for recurrent Clostridioides difficile infection.
Haber SL; Raney CRK; Larson TL; Lau JP
Am J Health Syst Pharm; 2019 Jun; 76(13):935-942. PubMed ID: 31361890
[TBL] [Abstract][Full Text] [Related]
18. Fecal microbiota transplantation (FMT) for C. difficile infection, just say 'No'.
Tan X; Johnson S
Anaerobe; 2019 Dec; 60():102092. PubMed ID: 31472233
[TBL] [Abstract][Full Text] [Related]
19. Durable reduction of Clostridioides difficile infection recurrence and microbiome restoration after treatment with RBX2660: results from an open-label phase 2 clinical trial.
Orenstein R; Dubberke ER; Khanna S; Lee CH; Yoho D; Johnson S; Hecht G; DuPont HL; Gerding DN; Blount KF; Mische S; Harvey A
BMC Infect Dis; 2022 Mar; 22(1):245. PubMed ID: 35279084
[TBL] [Abstract][Full Text] [Related]
20. Fecal microbiota-based treatment for recurrent Clostridioides difficile infection.
Walter J; Shanahan F
Cell; 2023 Mar; 186(6):1087. PubMed ID: 36931236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
